BCL2 and acute lymphoblastic leukemia: In order to confirm that venetoclax binds to BCL-2 we performed dose response CETSA in ALL-PO cells followed by western blot analysis, which demonstrated dose-dependent thermal stabilization of BCL-2 following venetoclax treatment (Supplementary Fig. 9).